Patents by Inventor Xiaobing Be

Xiaobing Be has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080178307
    Abstract: This invention provides compositions, organisms and methodologies employing a novel human gene encoding a protein that has sequence homology to a consensus sequence of calcineurin-like phosphoesterase family are disclosed. The novel protein is encoded by a human gene comprising 4 exons. The human gene is localized in the 10p15 locus of human chromosome 10. The sequence similarities between the novel human protein and the consensus sequence of calcineurin-like phosphoesterases indicate that the novel human protein may function as a calcineurin-like protein phosphatase.
    Type: Application
    Filed: April 16, 2007
    Publication date: July 24, 2008
    Applicant: Wyeth
    Inventors: Wei Liu, Leeying Wu, Roger Ford, Xiaobing Be
  • Publication number: 20070092529
    Abstract: Compositions and methods for diagnosing, monitoring, or treating cancers. Genes encoding transmembrane proteins that are over-expressed in colon, lung, breast, prostate, liver, stomach, esophagus, or kidney cancer tissues are identified. These transmembrane genes can be used as biological markers for the detection or diagnosis of cancers. These genes can also serve as targets for cancer therapeutics. In addition, these genes can also be used for screening for anti-cancer drugs.
    Type: Application
    Filed: August 23, 2006
    Publication date: April 26, 2007
    Applicant: Wyeth
    Inventors: Xiaobing Be, Wei Liu, Donna Slonim, Steve Howes
  • Patent number: 7208306
    Abstract: This invention provides compositions, organisms and methodologies employing a novel human gene encoding a protein that has sequence homology to a consensus sequence of calcineurin-like phosphoesterase family are disclosed. The novel protein is encoded by a human gene comprising 4 exons. The human gene is localized in the 10p15 locus of human chromosome 10. The sequence similarities between the novel human protein and the consensus sequence of calcineurin-like phosphoesterases indicate that the novel human protein may function as a calcineurin-like protein phosphatase.
    Type: Grant
    Filed: October 24, 2003
    Date of Patent: April 24, 2007
    Assignee: Wyeth
    Inventors: Wei Liu, Leeying Wu, Roger Ford, Xiaobing Be
  • Publication number: 20050119210
    Abstract: Compositions and methods for diagnosing, monitoring, or treating cancers. Genes encoding transmembrane proteins that are over-expressed in colon, lung, breast, prostate, liver, stomach, esophagus, or kidney cancer tissues are identified. These transmembrane genes can be used as biological markers for the detection or diagnosis of cancers. These genes can also serve as targets for cancer therapeutics. In addition, these genes can also be used for screening for anti-cancer drugs.
    Type: Application
    Filed: May 19, 2004
    Publication date: June 2, 2005
    Inventors: Xiaobing Be, Wei Liu, Donna Slonim, Steve Howes
  • Publication number: 20040091926
    Abstract: This invention provides compositions, organisms and methodologies employing a novel human gene encoding a protein that has sequence homology to a consensus sequence of calcineurin-like phosphoesterase family are disclosed. The novel protein is encoded by a human gene comprising 4 exons. The human gene is localized in the 10p15 locus of human chromosome 10. The sequence similarities between the novel human protein and the consensus sequence of calcineurin-like phosphoesterases indicate that the novel human protein may function as a calcineurin-like protein phosphatase.
    Type: Application
    Filed: October 24, 2003
    Publication date: May 13, 2004
    Applicant: Wyeth
    Inventors: Wei Liu, Leeying Wu, Roger Ford, Xiaobing Be